Studies from Beth Israel Deaconess Medical Center Add New Findings in the Area of COVID-19 (Tixagevimab-cilgavimab Decreases the Rate of Sars-cov-2 Infection Among Solid Organ Transplant Recipients)

  • Benham Saberi

Press/Media

Period3 Jan 2024

Media coverage

1

Media coverage

  • TitleStudies from Beth Israel Deaconess Medical Center Add New Findings in the Area of COVID-19 (Tixagevimab-cilgavimab Decreases the Rate of Sars-cov-2 Infection Among Solid Organ Transplant Recipients)
    Media name/outletNewsRx COVID-19 Daily
    Country/TerritoryUnited States
    Date3/01/24
    PersonsBenham Saberi
View all 1
View less